| Late dysphagia after IMRT for head and neck cancer and correlation with dose–volume parameters HR Mortensen, K Jensen, K Aksglæde, M Behrens, C Grau Radiotherapy and Oncology 107 (3), 288-294, 2013 | 159 | 2013 |
| Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer HR Mortensen, J Overgaard, L Specht, M Overgaard, J Johansen, ... Radiotherapy and oncology 103 (1), 69-75, 2012 | 111 | 2012 |
| Prophylactic swallowing exercises in head and neck cancer radiotherapy HR Mortensen, K Jensen, K Aksglæde, K Lambertsen, E Eriksen, C Grau Dysphagia 30, 304-314, 2015 | 92 | 2015 |
| Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer HR Mortensen, J Overgaard, K Jensen, L Specht, M Overgaard, ... Acta oncologica 52 (7), 1535-1542, 2013 | 86 | 2013 |
| Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer HR Mortensen, K Jensen, C Grau Acta Oncologica 52 (2), 270-276, 2013 | 75 | 2013 |
| The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma NM Lyhne, H Primdahl, CA Kristensen, E Andersen, J Johansen, ... Radiotherapy and Oncology 117 (1), 91-98, 2015 | 68 | 2015 |
| Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer M Thomas, HR Mortensen, L Hoffmann, DS Møller, EGC Troost, CT Muijs, ... Radiotherapy and Oncology 156, 102-112, 2021 | 20 | 2021 |
| Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe TE Kroese, HWM van Laarhoven, SF Schoppman, PRAJ Deseyne, ... European Journal of Cancer 185, 28-39, 2023 | 16 | 2023 |
| Strategies for motion robust proton therapy with pencil beam scanning for esophageal cancer DS Møller, PR Poulsen, A Hagner, M Dufour, M Nordsmark, TB Nyeng, ... International Journal of Radiation Oncology* Biology* Physics 111 (2), 539-548, 2021 | 13 | 2021 |
| Proton therapy for early breast cancer patients in the DBCG proton trial: planning, adaptation, and clinical experience from the first 43 patients M Fuglsang Jensen, LB Stick, M Høyer, CJS Kronborg, EL Lorenzen, ... Acta Oncologica 61 (2), 223-230, 2022 | 5 | 2022 |
| The promise of proton beam therapy for oesophageal cancer: a systematic review of dosimetric and clinical outcomes O Nicholas, S Prosser, HR Mortensen, G Radhakrishna, MA Hawkins, ... Clinical Oncology 33 (8), e339-e358, 2021 | 5 | 2021 |
| Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres L Hoffmann, H Mortensen, M Shamshad, M Berbee, N Bizzocchi, R Bütof, ... Radiotherapy and Oncology 172, 32-41, 2022 | 4 | 2022 |
| Defining dysphagia–a modified multi-professional Danish Delphi study AH Nielsen, SJ Eskildsen, J Danielsen, P Haastrup, AB Jellinghof, J Riis, ... Scandinavian Journal of Gastroenterology 58 (6), 583-588, 2023 | 3 | 2023 |
| Intrafraction tumor motion monitoring and dose reconstruction for liver pencil beam scanning proton therapy S Nankali, ES Worm, JB Thomsen, LB Stick, J Bertholet, M Høyer, ... Frontiers in oncology 13, 1112481, 2023 | 3 | 2023 |
| Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations ES Worm, R Hansen, M Høyer, B Weber, H Mortensen, PR Poulsen Physics in Medicine & Biology 66 (20), 205009, 2021 | 3 | 2021 |
| Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer M Shamshad, DS Møller, HR Mortensen, ML Ehmsen, MF Jensen, ... Acta Oncologica 61 (8), 994-1003, 2022 | 2 | 2022 |
| Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma AU Thuehøj, NC Andersen, ES Worm, M Høyer, EM Tabaksblat, B Weber, ... Acta Oncologica 61 (2), 197-201, 2022 | 2 | 2022 |
| Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience HR Mortensen, GE Villadsen, ES Worm, B Weber Scandinavian Journal of Gastroenterology 56 (3), 259-265, 2021 | 1 | 2021 |
| European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4). TE Kroese, S Bronzwaer, PSN van Rossum, SF Schoppman, ... European Journal of Cancer, 114062, 2024 | | 2024 |
| Proton versus photon therapy for esophageal cancer–A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton … HR Mortensen, P Populaire, L Hoffmann, DS Moeller, A Appelt, P Nafteux, ... Radiotherapy and Oncology 190, 2024 | | 2024 |
